We are live on
!
Find out more
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+10.53%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
+$1.25B
(+3.9%)
Cap. Flow
-$1.82B
Cap. Flow
% of AUM
-5.43%
Top 10 Holdings %
Top 10 Hldgs %
10.25%
Holding
1,526
New
88
Increased
442
Reduced
565
Closed
79
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mativ Holdings
MATV
|
+$106M |
| 2 |
Acacia Research
ACTG
|
+$101M |
| 3 |
Universal Corp
UVV
|
+$47.5M |
| 4 |
PARTNERRE LTD
PRE
|
+$41.9M |
| 5 |
Standard Motor Products
SMP
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MOLXA
MOLEX INC CL-A
MOLXA
|
+$314M |
| 2 |
Nu Skin
NUS
|
+$241M |
| 3 |
Lincoln Electric
LECO
|
+$116M |
| 4 |
HITK
HI-TECH PHARMACAL INC
HITK
|
+$64.5M |
| 5 |
Dorman Products
DORM
|
+$56.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.94% |
| 2 | Technology | 17.69% |
| 3 | Consumer Discretionary | 14.45% |
| 4 | Financials | 10.27% |
| 5 | Materials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1401
iShares 1-3 Year Treasury Bond ETF
SHY
$26.8B
| $50K | ﹤0.01% |
590
| – | – |
2013 Q2
1 quarter
|
|
|
INTX
1402
DELISTED
Intersections, Inc.
INTX
| $48K | ﹤0.01% |
5,500
| – | – |
2013 Q2
1 quarter
|
|
1403
Anika Therapeutics
ANIK
$277M
| $46K | ﹤0.01% |
1,900
| – | – |
2013 Q2
1 quarter
|
|
1404
DELISTED
Global Sources Ltd
GSOL
| $45K | ﹤0.01% |
6,000
| – | – |
2013 Q2
1 quarter
|
|
1405
International Tower Hill Mines
THM
$573M
| $44K | ﹤0.01% |
139,850
-788,072
| -85% | -$435K |
2013 Q2
1 quarter
|
|
|
ETRM
1406
DELISTED
EnteroMedics Inc.
ETRM
| $44K | ﹤0.01% |
33
-15
| -31% | -$17.5K |
2013 Q2
1 quarter
|
|
|
NSU
1407
DELISTED
Nevsun Resources Ltd.
NSU
| $43K | ﹤0.01% |
13,500
| – | – |
2013 Q2
1 quarter
|
|
1408
Bank of New York Mellon
BNY
$96.4B
| $41K | ﹤0.01% |
1,360
-340
| -20% | -$10.4K |
2013 Q2
1 quarter
|
|
1409
Lesaka Technologies
LSAK
$382M
| $40K | ﹤0.01% |
3,300
| – | – |
2013 Q2
1 quarter
|
|
1410
DELISTED
BAKER MICHAEL CORP
BKR
| $40K | ﹤0.01% |
1,000
-164,200
| -99% | -$6.07M |
2013 Q2
1 quarter
|
|
1411
Evolution Petroleum
EPM
$147M
| $39K | ﹤0.01% |
+3,500
| New | +$40.4K |
2013 Q3
0 quarters
|
|
1412
Dr. Reddy's Laboratories
RDY
$10.7B
| $38K | ﹤0.01% |
+5,000
| New | +$36.4K |
2013 Q3
0 quarters
|
|
1413
Safety Insurance
SAFT
$1.53B
| $37K | ﹤0.01% |
700
| – | – |
2013 Q2
1 quarter
|
|
|
LOCK
1414
DELISTED
LifeLock, Inc.
LOCK
| $37K | ﹤0.01% |
+2,500
| New | +$31.3K |
2013 Q3
0 quarters
|
|
1415
Sabine Royalty Trust
SBR
$1.05B
| $36K | ﹤0.01% |
700
| – | – |
2013 Q2
1 quarter
|
|
1416
DELISTED
Great Lakes Dredge & Dock
GLDD
| $33K | ﹤0.01% |
4,432
| – | – |
2013 Q2
1 quarter
|
|
|
HXM
1417
DELISTED
DESARROLLADORA HOMES DA DE CV (HOMEX DEV. CORP)
HXM
| $30K | ﹤0.01% |
14,100
| – | – |
2013 Q2
1 quarter
|
|
|
HITK
1418
DELISTED
HI-TECH PHARMACAL INC
HITK
| $30K | ﹤0.01% |
700
-1,684,925
| -100% | -$64.5M |
2013 Q2
1 quarter
|
|
1419
DELISTED
ASIAINFO-LINKAGE INC COM STK (DE)
ASIA
| $28K | ﹤0.01% |
2,400
| – | – |
2013 Q2
1 quarter
|
|
1420
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $28K | ﹤0.01% |
+2,375
| New | +$32.6K |
2013 Q3
0 quarters
|
|
1421
Century Casinos
CNTY
$22.4M
| $26K | ﹤0.01% |
4,500
-7,500
| -63% | -$34.2K |
2013 Q2
1 quarter
|
|
1422
SLB Ltd
SLB
$71.8B
| $25K | ﹤0.01% |
288
-72
| -20% | -$5.92K |
2013 Q2
1 quarter
|
|
|
GKNT
1423
DELISTED
GEEKNET INC COM NEW
GKNT
| $25K | ﹤0.01% |
1,500
| – | – |
2013 Q2
1 quarter
|
|
1424
Palatin Technologies
PTN
$11.6M
| $24K | ﹤0.01% |
28
| – | – |
2013 Q2
1 quarter
|
|
1425
KRONOS Worldwide
KRO
$852M
| $22K | ﹤0.01% |
1,400
-2,700
| -66% | -$42.5K |
2013 Q2
1 quarter
|
|
Similar funds
Royce & Associates's Q3 2013 Portfolio in Review
As of Q3 2013, Royce & Associates held 1,526 positions worth $33.6B, up 3.9% from $32.4B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Royce & Associates withdrew a net $1.82B in Q3 2013, closing 79 positions and reducing 565 holdings. Its most notable exit was MAIDENFORM BRANDS, INC, an estimated $44.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Royce & Associates opened a new position in Genesco worth $17.8M.
- Royce & Associates's largest Q3 2013 buy was Genesco: 272,129 shares worth $17.8M.
- Royce & Associates added most to Mativ Holdings in Q3 2013, an estimated $106M increase.
- Royce & Associates's biggest Q3 2013 reduction was MOLEX INC CL-A, cutting an estimated $314M.
- Royce & Associates fully exited MAIDENFORM BRANDS, INC in Q3 2013, selling an estimated $44.3M.
- Royce & Associates's ten largest holdings make up 10% of its $33.6B portfolio in Q3 2013.
- Royce & Associates opened 88 new positions and closed 79 in Q3 2013.
- Royce & Associates's portfolio value rose 3.9% quarter-over-quarter to $33.6B.
Based on Royce & Associates's 13F filing for Q3 2013, filed 12 Nov 2013.